Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2009, p. 977-986, Vol. 53, No. 3
0066-4804/09/$08.00+0 doi:10.1128/AAC.01155-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Alexey Ruzin,
Margareta Tuckman,
Melissa A. Visalli,
Peter J. Petersen, and
Patricia A. Bradford
Infectious Diseases Discovery Research, Wyeth Research, Pearl River, New York
Received 28 August 2008/ Returned for modification 19 October 2008/ Accepted 8 December 2008
TEM- and SHV-type extended-spectrum β-lactamases (ESBLs) are the most common ESBLs found in the United States and are prevalent throughout the world. Amino acid substitutions at a number of positions in TEM-1 lead to the ESBL phenotype, although substitutions at residues 104 (E to K), 164 (R to S or H), 238 (G to S), and 240 (E to K) appear to be particularly important in modifying the spectrum of activity of the enzyme. The SHV-1-derived ESBLs are a less diverse collection of enzymes; however, the majority of amino acid substitutions resulting in an ESBL mirror those seen in the TEM-1-derived enzymes. Pyrosequencing by use of the single-nucleotide polymorphism (SNP) protocol was applied to provide sequence data at positions critical for the ESBL phenotype spanning the blaTEM and blaSHV genes. Three novel β-lactamases are described: the ESBLs TEM-155 (Q39K, R164S, E240K) and SHV-105 (I8F, R43S, G156D, G238S, E240K) and a non-ESBL, SHV-48 (V119I). The ceftazidime, ceftriaxone, and aztreonam MICs for an Escherichia coli isolate expressing blaSHV-105 were >128, 128, and >128 µg/ml, respectively. Likewise, the ceftazidime, ceftriaxone, and aztreonam MICs for an E. coli isolate expressing blaTEM-155 were >128, 64, and > 128 µg/ml, respectively. Pyrosequence analysis determined the true identity of the β-lactamase on plasmid R1010 to be SHV-11 rather than SHV-1, as previously reported. Pyrosequencing is a real-time sequencing-by-synthesis approach that was applied to SNP detection for TEM- and SHV-type ESBL identification and represents a robust tool for rapid sequence determination that may have a place in the clinical setting.
Published ahead of print on 15 December 2008.
The first two authors contributed equally to the work described here.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»